Optimi Health Corp.’s Lock-Up Period Will Expire on November 16th (NASDAQ:OPTH)

Optimi Health’s (NASDAQ:OPTH) lock-up period is set to end on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its IPO on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Weiss Ratings raised Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. Wall Street Zen upgraded Optimi Health to a “hold” rating in a research note on Saturday, July 25th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Optimi Health Trading Down 9.2%

Shares of Optimi Health stock opened at $2.18 on Friday. Optimi Health has a 12-month low of $1.90 and a 12-month high of $6.40. The stock’s 50-day moving average price is $3.78. The company has a quick ratio of 0.03, a current ratio of 0.06 and a debt-to-equity ratio of 0.04.

About Optimi Health

Optimi Health Corp. is a Canadian psychedelics and mental-health company focused on the development, production and distribution of naturally derived psilocybin products and functional mushroom formulations. Its work is directed toward supporting emerging psychedelic-assisted therapies, research and wellness applications. The company operates a Health Canada-licensed manufacturing facility in Princeton, British Columbia, where it cultivates and processes mushrooms and develops products under regulated quality and production standards.